Your browser doesn't support javascript.
loading
Inclusion of hemimegalencephaly into the phenotypic spectrum of NPRL3 pathogenic variants in familial focal epilepsy with variable foci.
Canavati, Christina; Klein, Karl Martin; Afawi, Zaid; Pendziwiat, Manuela; Abu Rayyan, Amal; Kamal, Lara; Zahdeh, Fouad; Qaysia, Ikram; Helbig, Ingo; Kanaan, Moien.
Afiliação
  • Canavati C; Hereditary Research Laboratory, Bethlehem University, Bethlehem, Palestine.
  • Klein KM; Epilepsy Center Frankfurt Rhine-Main, Department of Neurology, Goethe University Frankfurt, University Hospital, Frankfurt, Germany.
  • Afawi Z; Departments of Clinical Neurosciences, Medical Genetics, and Community Health Sciences, Hotchkiss Brain Institute and Alberta Children's Hospital Research Institute, Cumming School of Medicine, Foothills Medical Centre, University of Calgary, Alberta, Canada.
  • Pendziwiat M; Tel Aviv University Medical School, Ramat Aviv, Israel.
  • Abu Rayyan A; Department of Neuropediatrics, University of Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Kamal L; Hereditary Research Laboratory, Bethlehem University, Bethlehem, Palestine.
  • Zahdeh F; Hereditary Research Laboratory, Bethlehem University, Bethlehem, Palestine.
  • Qaysia I; Hereditary Research Laboratory, Bethlehem University, Bethlehem, Palestine.
  • Helbig I; Department of Neurology, Al-Ahli Hospital, Hebron, Palestine.
  • Kanaan M; Department of Neuropediatrics, University of Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.
Epilepsia ; 60(6): e67-e73, 2019 06.
Article em En | MEDLINE | ID: mdl-31111464
ABSTRACT
Despite tremendous progress through next generation sequencing technologies, familial focal epilepsies are insufficiently understood. We sought to identify the genetic basis in multiplex Palestinian families with familial focal epilepsy with variable foci (FFEVF). Family I with 10 affected individuals and Family II with five affected individuals underwent detailed phenotyping over three generations. The phenotypic spectrum of the two families varied from nonlesional focal epilepsy including nocturnal frontal lobe epilepsy to severe structural epilepsy due to hemimegalencephaly. Whole-exome sequencing and single nucleotide polymorphism array analysis revealed pathogenic variants in NPRL3 in each family, a partial ~38-kb deletion encompassing eight exons (exons 8-15) and the 3'-untranslated region of the NPRL3 gene in Family I, and a de novo nonsense variant c.1063C>T, p.Gln355* in Family II. Furthermore, we identified a truncating variant in the PDCD10 gene in addition to the NPRL3 variant in a patient with focal epilepsy from Family I. The individual also had developmental delay and multiple cerebral cavernomas, possibly demonstrating a digenic contribution to the individual's phenotype. Our results implicate the association of NPRL3 with hemimegalencephaly, expanding the phenotypic spectrum of NPRL3 in FFEVF and underlining that partial deletions are part of the genotypic spectrum of NPRL3 variants.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Epilepsias Parciais / Proteínas Ativadoras de GTPase / Megalencefalia Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Epilepsias Parciais / Proteínas Ativadoras de GTPase / Megalencefalia Idioma: En Ano de publicação: 2019 Tipo de documento: Article